Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma.
Schmeusser BN, Patil DH, Midenberg E, Higgins MI, Zaldumbide J, Martini DJ, Steele S, Williams M, Nabavizadeh R, Psutka SP, Ogan K, Bilen MA, Master VA. Schmeusser BN, et al. Among authors: psutka sp. Data Brief. 2022 Nov 4;45:108724. doi: 10.1016/j.dib.2022.108724. eCollection 2022 Dec. Data Brief. 2022. PMID: 36426052 Free PMC article.
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
Bergerot CD, Malhotra J, Bergerot P, Philip EJ, Castro DV, Hsu J, Mota ACA, Cardoso de Azeredo A, Neto JNM, Hutson T, Grünwald V, Bex A, Psutka SP, Rini B, Plimack ER, Master V, Albiges L, Choueiri TK, Pal S, Powles T. Bergerot CD, et al. Among authors: psutka sp. Oncologist. 2023 Jun 2;28(6):494-500. doi: 10.1093/oncolo/oyad028. Oncologist. 2023. PMID: 36917626 Free PMC article.
Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: Study protocol for a randomized, controlled pilot and feasibility study.
Psutka SP, Veleber S, Siman J, Jannat S, Holt S, Wright JL, Greenlee H. Psutka SP, et al. Contemp Clin Trials Commun. 2022 Dec 5;30:101044. doi: 10.1016/j.conctc.2022.101044. eCollection 2022 Dec. Contemp Clin Trials Commun. 2022. PMID: 36561732 Free PMC article.
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Schmeusser BN, Midenberg E, Palacios AR, Ali AA, Patil DH, Higgins M, Nabavizadeh R, Croll B, Williams M, Sheehy J, Zheng B, Narayan VM, Joshi SS, Ogan K, Psutka SP, Bilen MA, Master VA. Schmeusser BN, et al. Among authors: psutka sp. Clin Genitourin Cancer. 2023 Aug;21(4):475-482.e4. doi: 10.1016/j.clgc.2023.04.005. Epub 2023 Apr 19. Clin Genitourin Cancer. 2023. PMID: 37210313
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.
Barbour AB, Kirste S, Grosu AL, Siva S, Louie AV, Onishi H, Swaminath A, Teh BS, Psutka SP, Weg ES, Chen JJ, Zeng J, Gore JL, Hall E, Liao JJ, Correa RJM, Lo SS. Barbour AB, et al. Among authors: psutka sp. Cancers (Basel). 2023 Jul 19;15(14):3672. doi: 10.3390/cancers15143672. Cancers (Basel). 2023. PMID: 37509333 Free PMC article. Review.
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma.
Kwok C, Khorasanchi A, Psutka SP, Hinkley M, Dason S, Sundi D, Yang Y, Yang Y, Verschraegen C, Gross EE, Orcutt D, Yin M. Kwok C, et al. Among authors: psutka sp. Front Oncol. 2023 Jul 27;13:1231831. doi: 10.3389/fonc.2023.1231831. eCollection 2023. Front Oncol. 2023. PMID: 37576889 Free PMC article.
Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year Efficacy and Safety Report of a Multicenter Cohort of Primary RCC Patients Treated with SABR.
Koehne EL, Psutka SP. Koehne EL, et al. Among authors: psutka sp. Ann Surg Oncol. 2023 Nov;30(12):6947-6949. doi: 10.1245/s10434-023-13755-2. Epub 2023 Jun 19. Ann Surg Oncol. 2023. PMID: 37335349 No abstract available.
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR. Panian J, et al. Oncologist. 2023 Jun 27:oyad166. doi: 10.1093/oncolo/oyad166. Online ahead of print. Oncologist. 2023. PMID: 37368355 Free article.
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis.
Hakimi K, Saidian A, Panian J, Barata P, Berg S, Chang SL, Saliby RM, Dzimitrowicz H, Emamekhoo H, Gross E, Kilari D, Lam E, Nguyen M, Meagher M, Wang L, Rauterkus GP, D'Andrea V, Yim K, Psutka S, Thapa B, Weise N, Zhang T, McKay RR, Derweesh IH. Hakimi K, et al. Clin Genitourin Cancer. 2023 Dec;21(6):694-702. doi: 10.1016/j.clgc.2023.07.007. Epub 2023 Jul 19. Clin Genitourin Cancer. 2023. PMID: 37558529
139 results